4th Quarter - Report

THE OB-C GROUP, LLC for EMERGENT BIOSOLUTIONS INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

No specific bill number: matters relating to Biomedical Advanced Research and Development Authority.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Homeland Security HOM

HR 3288, Consolidated Appropriations Act, 2010, Division D - Department of Labor, Health & Human Services and Education Appropriations Act of 2010: all provisions relating to the development, acquisition and stockpiling of biodefense vaccines. No specific bill number: matters relating to the BioShield Project. HR 2892, Department of Homeland Security Appropriations Act, 2010: all provisions relating to the development, acquisition and stockpiling of biodefense vaccines. S.1298, Department of Homeland Security Appropriations Act, 2010: all provisions relating to the development, acquisition and stockpiling of biodefense vaccines. S.1649, WMD Prevention and Prepardeness Act of 2009: all provisions relating to the development, acquisition and stockpiling of biodefense vaccines.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2892 (111th), S. 1649 (111th), H.R. 3288 (111th), S. 1298 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.